Goldman Sachs’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-55,300
| Closed | -$4.7M | – | 5758 |
|
|
2019
Q4 | $4.7M | Sell |
55,300
-15,000
| -21% | -$1M | ﹤0.01% | 3019 |
|
|
2019
Q3 | $3.52M | Buy |
70,300
+62,000
| +747% | +$2.47M | ﹤0.01% | 3118 |
|
|
2019
Q2 | $303K | Sell |
8,300
-42,500
| -84% | -$1.39M | ﹤0.01% | 4615 |
|
|
2019
Q1 | $1.42M | Sell |
50,800
-116,500
| -70% | -$2.75M | ﹤0.01% | 3858 |
|
|
2018
Q4 | $3.2M | Buy |
167,300
+127,300
| +318% | +$2.96M | ﹤0.01% | 3233 |
|
|
2018
Q3 | $1.2M | Hold |
40,000
| – | – | ﹤0.01% | 3936 |
|
|
2018
Q2 | $1.47M | Hold |
40,000
| – | – | ﹤0.01% | 3827 |
|
|
2018
Q1 | $1.32M | Sell |
40,000
-40,000
| -50% | -$1.25M | ﹤0.01% | 3870 |
|
|
2017
Q4 | $2.19M | Buy |
80,000
+40,000
| +100% | +$1.23M | ﹤0.01% | 3722 |
|
|
2017
Q3 | $1.48M | Sell |
40,000
-4,000
| -9% | -$147K | ﹤0.01% | 4241 |
|
|
2017
Q2 | $1.67M | Sell |
44,000
-3,500
| -7% | -$156K | ﹤0.01% | 3981 |
|
|
2017
Q1 | $2.32M | Sell |
47,500
-144,700
| -75% | -$6.6M | ﹤0.01% | 3599 |
|
|
2016
Q4 | $6.52M | Buy |
+192,200
| New | +$6.82M | ﹤0.01% | 2823 |
|
|
2016
Q3 | – | Sell |
-724,100
| Closed | -$24.4M | – | 7283 |
|
|
2016
Q2 | $24.4M | Sell |
724,100
-395,700
| -35% | -$14M | 0.01% | 1652 |
|
|
2016
Q1 | $35.6M | Buy |
1,119,800
+508,600
| +83% | +$16.6M | 0.01% | 1304 |
|
|
2015
Q4 | $22.8M | Sell |
611,200
-386,800
| -39% | -$14.6M | 0.01% | 1671 |
|
|
2015
Q3 | $37.9M | Buy |
+998,000
| New | +$35M | 0.01% | 1238 |
|
|
2015
Q2 | – | Sell |
-77,500
| Closed | -$2.17M | – | 7542 |
|
|
2015
Q1 | $2.17M | Sell |
77,500
-42,600
| -35% | -$1.2M | ﹤0.01% | 3706 |
|
|
2014
Q4 | $3.32M | Buy |
+120,100
| New | +$2.98M | ﹤0.01% | 3364 |
|
|
2014
Q2 | – | Sell |
-25,500
| Closed | -$725K | – | 7220 |
|
|
2014
Q1 | $725K | Hold |
25,500
| – | – | ﹤0.01% | 4958 |
|
|
2013
Q4 | $985K | Sell |
25,500
-31,400
| -55% | -$1.12M | ﹤0.01% | 4757 |
|
|
2013
Q3 | $1.91M | Sell |
56,900
-130,300
| -70% | -$4.15M | ﹤0.01% | 3960 |
|
|
2013
Q2 | $5.76M | Buy |
+187,200
| New | +$6.26M | ﹤0.01% | 2601 |
|
Other funds holding MDCO
Goldman Sachs's MDCO Position: Q1 2020 in Review
Goldman Sachs sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 986,518 shares — an estimated $83.8M sold.
Goldman Sachs first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $113M in Q3 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Goldman Sachs reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Goldman Sachs sold 986,518 Medicines Co shares in Q1 2020, an estimated $83.8M.
- Goldman Sachs first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Goldman Sachs's Medicines Co position peaked at $113M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.